Patient-specific compartmental models for [177Lu]LuPSMA-617 therapy

被引：0
|
作者：
Li, W. [1 ]
Kupitz, D. [2 ,3 ]
Spielmann, V. [1 ]
Kamp, A. [1 ]
Katzdobler, L. [1 ]
Giussani, A. [1 ]
Kreissl, M. [2 ,3 ,4 ]
Grosser, O. [2 ,3 ,4 ]
机构：
[1] Bundesamt Strahlenschutz, Oberschleissheim, Germany
[2] Otto von Guericke Univ, Univ Hosp Magdeburg, Dept Radiol & Nucl Med, Magdeburg, Germany
[3] Otto von Guericke Univ, Fac Med, Magdeburg, Germany
[4] Otto von Guericke Univ, Res Campus STIMULATE, Magdeburg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0920
引用
收藏
页码：S799 / S800
页数：2
相关论文
共 50 条
  • [1] Simplified patient-specific renal dosimetry in 177Lu therapy: a proof of concept
    Ligonnet, Thomas
    Pistone, Daniele
    Auditore, Lucrezia
    Italiano, Antonio
    Amato, Ernesto
    Campenni, Alfredo
    Schaefer, Niklaus
    Boughdad, Sarah
    Baldari, Sergio
    Gnesin, Silvano
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2021, 92 : 75 - 85
  • [2] [177Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney Disease
    Mercolli, Lorenzo
    Mingels, Clemens
    Manzini, Giulia
    Cumming, Paul
    Zeimpekis, Konstantinos
    Xue, Song
    Alberts, Ian
    Uehlinger, Dominik
    Rominger, Axel
    Shi, Kuangyu
    Afshar-Oromieh, Ali
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (10) : 1570 - 1573
  • [3] PROVIDING ADVICE TO 177Lu THERAPY PATIENTS UPON DISCHARGE-A PATIENT-SPECIFIC METHOD
    O'mahoney, Eoin
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 29 - 30
  • [4] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Nanabala, Raviteja
    Pillai, Maroor Raghavan Ambikalmajan
    Gopal, Buvaneswari
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 56 (06) : 313 - 322
  • [5] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Raviteja Nanabala
    Maroor Raghavan Ambikalmajan Pillai
    Buvaneswari Gopal
    Nuclear Medicine and Molecular Imaging, 2022, 56 : 313 - 322
  • [6] Characteristics, tolerance and effectiveness of patients aged more or less than 75 years treated with [177Lu]LuPSMA-617 as part of France's early access program
    Tonnelet, D.
    Farce, J.
    Agrigoroaie, L.
    Merlin, C.
    Cottereau, A.
    Chene, S.
    Bailly, C.
    Bros, M.
    Mourey, L.
    Lacombe, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S423 - S423
  • [7] Dosimetry in a patient with peritoneal dialysis treated with [177Lu]Lu-PSMA-617
    Glass, Kathrin
    Hendrik Hering, Andreas
    Heinzel, Alexander
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2024, 63 (03): : 221 - 223
  • [8] [177Lu]PSMA-617 radionuclide therapy shows promise
    Bradley, Conor A.
    NATURE REVIEWS UROLOGY, 2018, 15 (08) : 468 - 468
  • [9] [177Lu]PSMA-617 radionuclide therapy shows promise
    Conor A. Bradley
    Nature Reviews Urology, 2018, 15 : 468 - 468
  • [10] Patient-specific tumor dosimetry in mCRPC patients treated with 177Lu-PSMA-617
    Meyer, Catherine
    Mirando, David
    Adams, Tim
    Czernin, Johannes
    Calais, Jeremie
    Dahlbom, Magnus
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
12345